Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-FAPI PET/MRI vs 18F-FDG PET/CT and MRI for Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer
NCT07553741Completed
- Start
- Apr 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of 68Ga-FAPI-4 in breast cancer. Primary endpoints: 18F-FDG PET analysis and 68Ga-FAPI-04 PET analysis. Started Apr 2025; status: completed.
02
Drugs
68Ga-FAPI-4
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT07553741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07553741.